Proposal for the clinical detection and management of patients and their family members with familial myelodysplastic syndrome/acute leukemia predisposition syndromes
Authors:
- 9 July 2012
- journal article
- review article
- Published by Taylor & Francis in Leukemia & Lymphoma
- Vol. 54 (1) , 28-35
Abstract
As with most genetic cancer predisposition syndromes, inherited susceptibility to myelodysplastic syndrome (MDS) and acute leukemia (AL) is likely to be more common than previously appreciated. As next-generation sequencing technologies become integrated into clinical practice, we anticipate that the number of cases of familial MDS/AL identified will increase. Although the existence of syndromes predisposing to MDS/AL has been known for some time, clinical guidelines for the screening and management of suspected or confirmed cases do not exist. Based on our collective experience caring for families with these syndromes, we propose recommendations for genetic counseling, testing, and clinical management. We welcome discussion about these proposals and hope that they will catalyze an ongoing dialog leading to optimal medical and psychosocial care for these patients.Keywords
This publication has 35 references indexed in Scilit:
- Draft consensus guidelines for diagnosis and treatment of Shwachman‐Diamond syndromeAnnals of the New York Academy of Sciences, 2011
- Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemiaNature Genetics, 2011
- Managing individuals with propensity to myeloid malignancies due to germline RUNX1 deficiencyHaematologica, 2011
- Inherited bone marrow failure syndromesHaematologica, 2010
- Therapy-Related Myeloid LeukemiaSeminars in Oncology, 2008
- Mutation ofCEBPAin Familial Acute Myeloid LeukemiaNew England Journal of Medicine, 2004
- In vitro analyses of known and novel RUNX1/AML1 mutations in dominant familial platelet disorder with predisposition to acute myelogenous leukemia: implications for mechanisms of pathogenesisBlood, 2002
- Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemiaNature Genetics, 1999
- The genetics of familial leukemiaLeukemia, 1997
- Familial Leukaemia: A Study of 909 FamiliesScandinavian Journal of Haematology, 1975